Johnson & Johnson in early talks to buy drugmaker Actelion

Shares of Johnson & Johnson rose $1.06 to $114.13 Friday.

FILE - In this July 16, 2012, file photo, Johnson & Johnson products are displayed in Orlando, Fla. On Friday, Nov. 25, 2016, Johnson & Johnson said it is in early talks to buy Swiss drugmaker Actelion Pharmaceuticals Ltd. Both companies said there is no certainty that a deal will happen. (AP Photo/John Raoux, File)

NEW YORK (AP) — Johnson & Johnson said Friday that is in early talks to buy the Swiss drugmaker Actelion Pharmaceuticals.

Actelion Pharmaceuticals Ltd. makes high blood pressure medicines that treat arteries in the lung and around the heart. Johnson & Johnson of New Brunswick, New Jersey, develops drugs and manufactures medical devices and other consumer products.

Shares of Johnson & Johnson rose $1.06 to $114.13 Friday.


Copyright 2016 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.